RedHill Biopharma Ltd. Email Format
Pharmaceutical ManufacturingNorth Carolina, United States11-50 Employees
RedHill Biopharma Ltd. is a specialty biopharmaceutical company focused on therapies for gastrointestinal and infectious diseases. Its U.S. commercial operations are headquartered in Raleigh, North Carolina, supported by a sales organization dedicated to gastrointestinal products. The company maintains a development pipeline with candidates in advanced clinical stages aimed at addressing unmet medical needs, with potential advantages in cost and speed to market relative to some new chemical entities. Its portfolio draws on multiple technology platforms and disease targets to diversify risk, under the oversight of an international leadership and advisory team with experience across Israel, the U.S., Canada, and Europe. Recently, RedHill announced an exclusive worldwide development and commercialization licensing agreement for RHB-102 with Hyloris Pharmaceuticals SA, excluding North America.